Boxer Capital LLC 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 1:13 pm Sale | 2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 698,861 2.000% | -1,540,000 (-68.78%) | Filing |
| 2022-02-14 4:54 pm Sale | 2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 2,238,861 7.500% | -238,333 (-9.62%) | Filing |
| 2021-02-16 4:57 pm Purchase | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 2,477,194 8.300% | 700,000 (+39.39%) | Filing |
| 2020-08-03 4:31 pm Purchase | 2020-07-23 | 13G | Milestone Pharmaceuticals Inc. MIST | Boxer Capital LLC | 1,777,194 7.200% | 1,777,194 (New Position) | Filing |